FROM PATENT TO PRODUCT: COMMERCIALIZING AN INNOVATION IN VASCULAR ACCESS FOR HEMODIALYSIS TREATMENT by Adeboye, Alan et al.
FROM PATENT TO PRODUCT: COMMERCIALIZING AN INNOVATION IN 
VASCULAR ACCESS FOR HEMODIALYSIS TREATMENT 
Alan Adeboye, Rishi Chandra, Kyle Moes, Jim Plew, Eric Wolf (Mangilal 
Agarwal, George Akingba), Center for Research and Learning, Innovation-to-
Enterprise Central (ITEC) Research Program, Indiana University–Purdue 
University Indianapolis, Indianapolis, Indiana 46202 
 
As End-Stage Renal Disease (ESRD) affects more than 500,000 patients 
every year and is currently increasing at a rate of 5-7%, the need for 
effective hemodialysis treatment remains an important issue in our society. 
Currently there are two vascular access devices widely accepted by the 
medical community, the arteriovenous graft (AVG) and arteriovenous fistula 
(AVF). Dr. Akingba’s innovation, the modular anastomotic valve device 
(MAVD), would allow for selective shunting during hemodialysis treatment in 
turn increasing the patency by an expected six fold. The purpose of our 
research pertaining to this device was to assist Dr. Akingba in preparing the 
device for commercialization through an analysis of FDA regulations, 
licensing, technological considerations, and medical device competitors. With 
this is mind, preliminary research, bench top model, flow dynamic computer 
simulations, and key interviews were implemented as data sources. 
Research in hemodialysis techniques, flow dynamics, FDA approval process, 
and licensing considerations including the valuation of the intellectual 
property has provided us insight into the most effective pathway to bring the 
MAVD to market. As a result, a more direct licensing plan was developed for 
Dr. Akingba to streamline the commercialization process. With this research, 
Dr. Akingba will be able to obtain FDA clearance through animal testing and 
clinical trials. Once this device has been brought to market, it will shift 
preference in vascular access toward usage of the graft for hemodialysis 
with its increased patency and ultimately bring medical enhancements to 
patients, surgeons, hospitals, and the health-care industry in general. 
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